599 Single-agent Safety and Activities of Target-Preserving Anti-Ctla-4 Antibody Gotistobart (ONC-392/BNT316) in PD-(L)1 Resistant Metastatic NSCLC and Population PK Analysis in Patients with Solid Tumors